These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12764364)

  • 21. Autologous bone marrow transplantation for leukemia.
    Stuart RK
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy versus transplantation: I. Acute myelogenous leukemia.
    Gale RP; Butturini A
    Haematologica; 1989; 74(1):1-4. PubMed ID: 2498172
    [No Abstract]   [Full Text] [Related]  

  • 23. Grade IV graft-versus-host disease and a 1-year remission following donor leukocyte transfusion for treatment of relapsed acute lymphoblastic leukemia.
    Kawakami T; Umehara S; Fukunaga M; Ishiko Y; Nishikawa K; Shiraki K
    Bone Marrow Transplant; 1996 Mar; 17(3):464-5. PubMed ID: 8704710
    [No Abstract]   [Full Text] [Related]  

  • 24. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
    Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
    Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
    De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J
    Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follow-up 26 years after treatment for acute myelogenous leukemia.
    Clift RA; Thomas ED;
    N Engl J Med; 2004 Dec; 351(23):2456-7. PubMed ID: 15575071
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of refractory and relapsed acute myelogenous leukemia.
    Stanisic S; Kalaycio M
    Expert Rev Anticancer Ther; 2002 Jun; 2(3):287-95. PubMed ID: 12113052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia.
    Brochstein JA; Kernan NA; Groshen S; Cirrincione C; Shank B; Emanuel D; Laver J; O'Reilly RJ
    N Engl J Med; 1987 Dec; 317(26):1618-24. PubMed ID: 3317056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation.
    Loren AW; Porter DL
    Bone Marrow Transplant; 2008 Mar; 41(5):483-93. PubMed ID: 18026156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow transplantation in leukemia.
    Gale RP
    Ann Clin Res; 1981; 13(4-5):367-72. PubMed ID: 7039488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukemia: management of relapse after allogeneic bone marrow transplantation.
    Kumar L
    J Clin Oncol; 1994 Aug; 12(8):1710-7. PubMed ID: 8040682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation.
    Pfrepper C; Klink A; Behre G; Schenk T; Franke GN; Jentzsch M; Schwind S; Al-Ali HK; Hochhaus A; Niederwieser D; Sayer HG
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):317-24. PubMed ID: 26424692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of acute myelogenous leukemia].
    Ono R
    Nihon Naika Gakkai Zasshi; 1992 Jul; 81(7):1040-5. PubMed ID: 1383364
    [No Abstract]   [Full Text] [Related]  

  • 34. A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Elmaagacli AH; Beelen DW; Schaefer UW
    Bone Marrow Transplant; 1997 Dec; 20(12):1045-55. PubMed ID: 9466277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of acute myelogenous leukaemia.
    Löwenberg B
    J Intern Med Suppl; 1997; 740():17-22. PubMed ID: 9350177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation.
    Bär BM; Schattenberg A; Mensink EJ; Geurts Van Kessel A; Smetsers TF; Knops GH; Linders EH; De Witte T
    J Clin Oncol; 1993 Mar; 11(3):513-9. PubMed ID: 8445426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donor buffy-coat infusion and chemotherapy for leukemia in relapse after marrow transplantation.
    Bogdanić V; Aurer I; Hitrec V; Boban D; Nemet D; Zupancić-Salek S; Labar B
    Haematologica; 1995; 80(4):338-40. PubMed ID: 7590504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced-intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Baron F; Labopin M; Peniket A; Jindra P; Afanasyev B; Sanz MA; Deconinck E; Nagler A; Mohty M
    Cancer; 2015 Apr; 121(7):1048-55. PubMed ID: 25424330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Donor leukocyte transfusion for relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation].
    Murata R; Shiohara S; Nakao S
    Rinsho Ketsueki; 2000 Apr; 41(4):288-91. PubMed ID: 10846457
    [No Abstract]   [Full Text] [Related]  

  • 40. Donor leukocyte infusions in acute lymphocytic leukemia.
    Collins RH; Goldstein S; Giralt S; Levine J; Porter D; Drobyski W; Barrett J; Johnson M; Kirk A; Horowitz M; Parker P
    Bone Marrow Transplant; 2000 Sep; 26(5):511-6. PubMed ID: 11019840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.